Published in Stem Cells Transl Med on May 27, 2015
Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol (2004) 101.91
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
Stem cells, cancer, and cancer stem cells. Nature (2001) 50.27
The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (2007) 49.11
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med (2012) 44.56
Identification of human brain tumour initiating cells. Nature (2004) 38.87
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med (1997) 32.63
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature (2006) 27.91
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature (2006) 24.52
Identification and expansion of human colon-cancer-initiating cells. Nature (2006) 24.44
The clonal evolution of tumor cell populations. Science (1976) 24.39
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature (1994) 21.59
lumi: a pipeline for processing Illumina microarray. Bioinformatics (2008) 17.19
Efficient tumour formation by single human melanoma cells. Nature (2008) 16.35
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res (2004) 14.73
CNS stem cells express a new class of intermediate filament protein. Cell (1990) 11.96
Clonal evolution in cancer. Nature (2012) 11.07
Tumor growth need not be driven by rare cancer stem cells. Science (2007) 10.34
Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature (2010) 8.48
Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell (2009) 7.09
Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell (2009) 6.77
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell (2012) 6.71
Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci U S A (1978) 6.51
Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature (2011) 6.39
CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res (2007) 6.21
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci U S A (2013) 5.68
MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS. Cancer Res (1964) 5.11
LeX/ssea-1 is expressed by adult mouse CNS stem cells, identifying them as nonependymal. Neuron (2002) 4.52
Evolution of the cancer stem cell model. Cell Stem Cell (2014) 4.38
Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature (2012) 4.13
SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell (2009) 3.89
Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell (2010) 3.70
TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma. Cancer Cell (2010) 3.69
Neuronal fate determinants of adult olfactory bulb neurogenesis. Nat Neurosci (2005) 3.67
Cellular heterogeneity: do differences make a difference? Cell (2010) 3.57
A multigene predictor of outcome in glioblastoma. Neuro Oncol (2009) 3.57
A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell (2010) 3.34
Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts. Proc Natl Acad Sci U S A (1976) 3.12
Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature (2012) 2.96
Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell (2012) 2.85
Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest (2008) 2.79
The brain tumor microenvironment. Glia (2011) 2.13
Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens. Stem Cells (2009) 1.96
Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution. Oncogene (2009) 1.85
An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours. J Neurosci Methods (2009) 1.82
Multipotent CD15+ cancer stem cells in patched-1-deficient mouse medulloblastoma. Cancer Res (2009) 1.79
Sox-2 is expressed by neural progenitors and astroglia in the adult rat brain. Neurosci Lett (2004) 1.69
LeX is expressed by principle progenitor cells in the embryonic nervous system, is secreted into their environment and binds Wnt-1. Dev Biol (2006) 1.52
Immunohistochemical localization of the early embryonic antigen (SSEA-1) in postimplantation mouse embryos and fetal and adult tissues. Dev Biol (1981) 1.49
NG2+ glial cells: a novel glial cell population in the adult brain. J Neuropathol Exp Neurol (1999) 1.49
Interactions between primordial germ cells play a role in their migration in mouse embryos. Development (1994) 1.33
An 'oligarchy' rules neural development. Trends Neurosci (2002) 1.29
CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors. BMC Cancer (2010) 1.26
Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin. Br J Cancer (2012) 1.25
Glioma cell populations grouped by different cell type markers drive brain tumor growth. Cancer Res (2010) 1.24
CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res (1994) 1.18
Brain cancer stem cells. J Mol Med (Berl) (2009) 1.18
Brain Tumor Stem-Like Cells Identified by Neural Stem Cell Marker CD15. Transl Oncol (2009) 1.06
Tumor-associated neutrophils as a new prognostic factor in cancer: a systematic review and meta-analysis. PLoS One (2014) 1.05
The role of CD15-(Le(X))-related carbohydrates in neutrophil adhesion. Histochem J (1992) 1.01
Pathologic analysis of primary brain tumors. Neurol Clin (1985) 1.00
Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer (1994) 0.98
Implementation of neuro-oncology service reconfiguration in accordance with NICE guidance provides enhanced clinical care for patients with glioblastoma multiforme. Br J Cancer (2011) 0.98
Genetic and functional diversity of propagating cells in glioblastoma. Stem Cell Reports (2014) 0.96
The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma. Neuro Oncol (2012) 0.94
Cancer stem cells as 'units of selection'. Evol Appl (2012) 0.94
Contributions to drug resistance in glioblastoma derived from malignant cells in the sub-ependymal zone. Cancer Res (2014) 0.93
NG2 expression in glioblastoma identifies an actively proliferating population with an aggressive molecular signature. Neuro Oncol (2011) 0.92
A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters. J Neuropathol Exp Neurol (1997) 0.90
Brain cancer stem cells: Think twice before going flat. Cell Stem Cell (2009) 0.89
Expression of glial fibrillary acidic protein, actin, fibronectin and factor VIII antigen in human astrocytomas. Pathology (1983) 0.83
High-grade astrocytomas show increased Nestin and Wilms's tumor gene (WT1) protein expression. Int J Surg Pathol (2009) 0.83
Glioma stem cells: better flat than round. Cell Stem Cell (2009) 0.83
A review of the role of stem cells in the development and treatment of glioma. Acta Neurochir (Wien) (2012) 0.82
Glioblastoma cell lines derived under serum-free conditions can be used as an in vitro model system to evaluate therapeutic response. Cancer Lett (2011) 0.77
Expression of non-glial intermediate filament proteins in gliomas. Clin Neuropathol (1994) 0.76
Rapid immunocytochemical analysis of acute leukemias. Am J Clin Pathol (1992) 0.75